Immatics at Immuno-Oncology Summit 2019 (Aug 5-9) in Boston, MA

| News, USA

Meet Immatics at this year’s I-O Summit and join CMO Carsten Reinhardt at the 2nd Bispecific Antibodies for Cancer Immunotherapy Conference for Immatics updates on biotherapeutics in Immuno-Oncology

Wednesday, Aug 7, 5.15 – 5.45pm EST

Track: Engineering Bispecific and Multi-Specific Antibodies

TCER® Bispecific Molecules: TCR-Based T-cell Engaging Receptors for the Treatment of Cancer

Speaker: Carsten Reinhardt, CMO Immatics

 

We’re looking forward to interesting and exciting discussions.

Further information on Immuno-Oncology Summit 2019 here

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.